Evidence map›Paper›PMID 24687855›Full record

ArticleMolecular and cellular biology2014

Unraveling the complexities of DNA-dependent protein kinase autophosphorylation.

Jessica A Neal, Seiji Sugiman-Marangos, Pamela VanderVere-Carozza, Mike Wagner, John Turchi, Susan P Lees-Miller, Murray S Junop, Katheryn Meek

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Review
  2. Review
  3. Secrets of DNA-PKcs beyond DNA repair.NPJ precision oncology · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. OGT and OGA: Sweet guardians of the genome.The Journal of biological chemistry · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jessica A NealCollege of Veterinary Medicine, Department of Microbiology and Molecular Genetics, and Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA.
Seiji Sugiman-MarangosDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
Pamela VanderVere-CarozzaDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Mike WagnerDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
John TurchiDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA Departments of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Susan P Lees-MillerDepartments of Biochemistry and Molecular Biology and Oncology, University of Calgary, Calgary, Alberta, Canada.
Murray S JunopDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
Katheryn MeekCollege of Veterinary Medicine, Department of Microbiology and Molecular Genetics, and Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA kmeek@msu.edu.

Funding

Relevant Targets of the DNA Dependent Protein KinaseR01AI048758 · NIAID · MICHIGAN STATE UNIVERSITY · PI MEEK, KATHERYN D · 2000 to 2016
$5.2M
NIAID NIH HHS AI048758NIAID NIH HHS R01 AI048758PHS HHS MOP-89903
6 · The paper itself

Abstract

DNA-dependent protein kinase (DNA-PK) orchestrates DNA repair by regulating access to breaks through autophosphorylations within two clusters of sites (ABCDE and PQR). Blocking ABCDE phosphorylation (by alanine mutation) imparts a dominant negative effect, rendering cells hypersensitive to agents that cause DNA double-strand breaks. Here, a mutational approach is used to address the mechanistic basis of this dominant negative effect. Blocking ABCDE phosphorylation hypersensitizes cells to most types of DNA damage (base damage, cross-links, breaks, and damage induced by replication stress), suggesting that DNA-PK binds DNA ends that result from many DNA lesions and that blocking ABCDE phosphorylation sequesters these DNA ends from other repair pathways. This dominant negative effect requires DNA-PK's catalytic activity, as well as phosphorylation of multiple (non-ABCDE) DNA-PK catalytic subunit (DNA-PKcs) sites. PSIPRED analysis indicates that the ABCDE sites are located in the only contiguous extended region of this huge protein that is predicted to be disordered, suggesting a regulatory role(s) and perhaps explaining the large impact ABCDE phosphorylation has on the enzyme's function. Moreover, additional sites in this disordered region contribute to the ABCDE cluster. These data, coupled with recent structural data, suggest a model whereby early phosphorylations promote initiation of nonhomologous end joining (NHEJ), whereas ABCDE phosphorylations, potentially located in a "hinge" region between the two domains, lead to regulated conformational changes that initially promote NHEJ and eventually disengage NHEJ.

Indexed as

Amino Acid SequenceAnimalsBinding SitesCHO CellsCisplatinCricetinaeCricetulusDNA-Activated Protein KinaseDNA AdductsDNA DamageEnzyme ActivationGenes, DominantMicrotubulesModels, MolecularMolecular Sequence DataPhenotypeCisplatinDNA-Activated Protein KinaseDNA AdductsVDJ Recombinases

Identifiers

PMID24687855
PMCPMC4054291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.